Published in Am J Geriatr Psychiatry on October 01, 2010
Comorbidity profile and healthcare utilization in elderly patients with serious mental illnesses. Am J Geriatr Psychiatry (2013) 1.10
Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation. Implement Sci (2013) 0.83
Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness. Gen Hosp Psychiatry (2015) 0.79
Antipsychotic Cardiometabolic Side Effect Monitoring in a State Community Mental Health System. Community Ment Health J (2015) 0.76
Diabetes and Cardiovascular Care Among People with Severe Mental Illness: A Literature Review. J Gen Intern Med (2016) 0.75
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet (2010) 14.24
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
A proposed 'health literate care model' would constitute a systems approach to improving patients' engagement in care. Health Aff (Millwood) (2013) 3.66
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med (2006) 2.80
Handheld computer use in U.S. family practice residency programs. J Am Med Inform Assoc (2001) 2.71
Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care (2002) 2.68
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study. Am J Psychiatry (2007) 2.68
Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med (2006) 2.49
Context matters: the experience of 14 research teams in systematically reporting contextual factors important for practice change. Ann Fam Med (2013) 2.30
Early evaluations of the medical home: building on a promising start. Am J Manag Care (2012) 2.18
Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Ann Intern Med (2015) 2.15
Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv (2007) 1.99
Risk of coronary artery disease in type 2 diabetes and the delivery of care consistent with the chronic care model in primary care settings: a STARNet study. Med Care (2007) 1.87
Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med (2010) 1.86
Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci (2006) 1.83
Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull (2006) 1.75
Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis (2012) 1.75
Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry (2004) 1.75
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry (2007) 1.73
Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull (2004) 1.73
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia. Schizophr Bull (2007) 1.72
Update in perioperative medicine. Ann Intern Med (2004) 1.71
Postoperative complications in the seriously mentally ill: a systematic review of the literature. Ann Surg (2008) 1.69
Family support, diet, and exercise among older Mexican Americans with type 2 diabetes. Diabetes Educ (2005) 1.61
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design. J Clin Psychiatry (2003) 1.56
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study. Bipolar Disord (2011) 1.50
How inclusive leadership can help your practice adapt to change. Fam Pract Manag (2012) 1.50
Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review. Eur Urol (2012) 1.47
The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS). Psychiatry Res (2007) 1.45
The impact of epilepsy on health status among younger and older adults. Epilepsia (2005) 1.43
Family support and diet barriers among older Hispanic adults with type 2 diabetes. Fam Med (2004) 1.40
Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure. J Manag Care Pharm (2006) 1.35
The challenges of multimorbidity from the patient perspective. J Gen Intern Med (2007) 1.35
Milk thistle for the treatment of liver disease: a systematic review and meta-analysis. Am J Med (2002) 1.28
Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med (2010) 1.26
Results of phase 3 of the CATIE schizophrenia trial. Schizophr Res (2008) 1.23
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation (2013) 1.20
Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv (2003) 1.17
The importance of relational coordination and reciprocal learning for chronic illness care within primary care teams. Health Care Manage Rev (2012) 1.15
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacology (2007) 1.13
Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res (2009) 1.13
Comparing the efficacy of interventions that use environmental supports to improve outcomes in patients with schizophrenia. Schizophr Res (2008) 1.12
Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder. J Affect Disord (2007) 1.11
Unforeseen inpatient mortality among veterans with schizophrenia. Med Care (2006) 1.09
Ethnicity and diagnostic patterns in veterans with psychoses. Soc Psychiatry Psychiatr Epidemiol (2004) 1.08
How the relationship of attitudes toward mental health treatment and service use differs by age, gender, ethnicity/race and education. Soc Psychiatry Psychiatr Epidemiol (2009) 1.07
Association of suboptimal prescribing and change in lower extremity physical function over time. Gerontology (2008) 1.07
Assessing appropriateness of lipid management among patients with diabetes mellitus: moving from target to treatment. Circ Cardiovasc Qual Outcomes (2012) 1.06
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial. Psychiatr Serv (2006) 1.05
Transition from military to VHA care: psychiatric health services for Iraq/Afghanistan combat-wounded. J Affect Disord (2010) 1.04
A logic model framework for evaluation and planning in a primary care practice-based research network (PBRN). J Am Board Fam Med (2011) 1.04
Cancer rates, medical comorbidities, and treatment modalities in the oldest patients. Crit Rev Oncol Hematol (2008) 1.03
Trail making test errors and executive function in schizophrenia and depression. Clin Neuropsychol (2006) 1.03
Implementing quality improvement in small, autonomous primary care practices: implications for the patient-centred medical home. Qual Prim Care (2011) 1.00
Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep (2013) 0.99
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania. J Clin Psychiatry (2003) 0.99
Racial disparity in the use of atypical antipsychotic medications among veterans. Am J Psychiatry (2003) 0.99
New-onset geriatric epilepsy care: Race, setting of diagnosis, and choice of antiepileptic drug. Epilepsia (2008) 0.99
Relationship quality and patient-assessed quality of care in VA primary care clinics: development and validation of the work relationships scale. Ann Fam Med (2013) 0.99
Features of the Chronic Care Model (CCM) associated with behavioral counseling and diabetes care in community primary care. J Am Board Fam Med (2010) 0.98
Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis (2008) 0.98
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2011) 0.98
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposure. Drugs Aging (2013) 0.96
Understanding differences in electronic health record (EHR) use: linking individual physicians' perceptions of uncertainty and EHR use patterns in ambulatory care. J Am Med Inform Assoc (2013) 0.94
The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings. J Clin Psychiatry (2003) 0.94
Antiepileptic drug monotherapy exposure and suicide-related behavior in older veterans. J Am Geriatr Soc (2012) 0.93
A brief cognitive assessment for use with schizophrenia patients in community clinics. Schizophr Res (2004) 0.93
Real-world antipsychotic treatment practices. Psychiatr Clin North Am (2007) 0.93
Medical comorbidity among youth diagnosed with bipolar disorder in the United States. J Clin Psychiatry (2009) 0.93
Does cognitive function improve with quetiapine in comparison to haloperidol? Schizophr Res (2002) 0.92
The Mount Sinai conference on the pharmacotherapy of schizophrenia. Schizophr Bull (2002) 0.92
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2013) 0.92
Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy (2005) 0.92
Effect of strengths model versus assertive community treatment model on participant outcomes and utilization: two-year follow-up. Psychiatr Rehabil J (2003) 0.90
Organizing care for complex patients in the patient-centered medical home. Ann Fam Med (2012) 0.90
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol Med (2005) 0.89
Polypharmacy with antipsychotic drugs in patients with schizophrenia: trends in multiple health care systems. Am J Health Syst Pharm (2014) 0.88
Medication adherence, ethnicity, and the influence of multiple psychosocial and financial barriers. Adm Policy Ment Health (2011) 0.88
Pulmonary disease among inpatient decedents: Impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.88
Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on contamination levels of methicillin-resistant Staphylococcus aureus. BMC Infect Dis (2014) 0.87
Association between self-monitoring of blood glucose and glycemic control in patients with type 2 diabetes mellitus. Am J Health Syst Pharm (2004) 0.87
Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier. Prim Care Diabetes (2012) 0.87
Clinical and demographic factors associated with homelessness and incarceration among VA patients with bipolar disorder. Am J Public Health (2009) 0.86
Preoperative evaluation for postoperative pulmonary complications. Med Clin North Am (2003) 0.86
The mental health treatment study. Psychiatr Rehabil J (2008) 0.85
Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC Fam Pract (2014) 0.84
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events. Circulation (2002) 0.84